Structures by: Hamou Ahabchane N. O.
Total: 6
1-(3-Phenyl-1<i>H</i>-pyrazol-5-yl)-1,2,3,4-tetrahydroquinoxaline-2,3-dione
C17H12N4O2
IUCrData (2017) 2, 2 x170073
a=12.6320(6)Å b=9.3954(4)Å c=12.3733(6)Å
α=90° β=102.7080(10)° γ=90°
1-Ethyl-4-phenyl-1,5-benzodiazepine-2-thione
C17H16N2S
IUCrData (2017) 2, 1 x161998
a=8.4001(8)Å b=9.6239(9)Å c=18.0037(18)Å
α=90° β=90° γ=90°
1-(1,3-Benzothiazol-2-yl)-3-(2-hydroxyethyl)imidazolidin-2-one
C12H13N3O2S
Acta Crystallographica Section E (2020) 76, 3 370-376
a=7.2863(2)Å b=13.9178(5)Å c=11.6156(4)Å
α=90° β=98.8660(10)° γ=90°
(2<i>Z</i>)-2-(2,4-Dichlorobenzylidene)-4-nonyl-3,4-dihydro-2<i>H</i>-1,4-benzothiazin-3-one
C24H27Cl2NOS
Acta Crystallographica Section E (2020) 76, 2 281-287
a=8.9961(3)Å b=10.3755(3)Å c=13.2565(4)Å
α=73.8570(10)° β=88.1190(10)° γ=74.1820(10)°
1-Benzyl-3-[(1-benzyl-1<i>H</i>-1,2,3-triazol-5-yl)methyl]-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one monohydrate
C24H21N5O,H2O
Acta Crystallographica Section E (2020) 76, 1 95-101
a=9.0872(2)Å b=21.1012(4)Å c=11.7134(2)Å
α=90° β=112.6540(10)° γ=90°
1-Methyl-3-(prop-2-yn-1-yl)-2,3-dihydro-1<i>H</i>-1,3-benzodiazol-2-one
C11H10N2O
Acta Crystallographica Section E (2019) 75, 12 1940-1946
a=7.1507(3)Å b=8.8177(4)Å c=15.4602(7)Å
α=90° β=97.914(2)° γ=90°